We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Risk of Birth Defects After Use of Acyclovir, Valacyclovir, and Famciclovir in the First Trimester—Reply

Björn Pasternak, MD, PhD; Anders Hviid, MSc, DrMedSci
JAMA. 2010;304(20):2242-2243. doi:10.1001/jama.2010.1702.
Text Size: A A A
Published online


In Reply: Drs Hou and Zhang note the limitation related to use of filled prescriptions as a proxy for drug exposure in our study. Because it is not known whether women actually used the drugs they purchased from the pharmacy, misclassification of exposure because of nonadherence may have introduced a bias toward the null. However, using a nationwide registry on filled prescriptions also has several advantages.

In view of the difficulties in performing studies of drug safety in pregnancy because of the relative rarity of both exposure and outcome, the use of nationwide registry data allows the identification of a sufficient number of exposed pregnancies to reach adequate power, at least for birth defects in aggregate. Furthermore, antivirals are prescribed for acute infections, and women who filled prescriptions for these drugs are therefore more likely to have used the drugs compared with (as an example) those who filled prescriptions for drugs prescribed for prophylactic indications. Moreover, people who fill prescriptions for drugs seem very likely to have used them since they have traveled to a pharmacy and purchased the drugs.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




November 24, 2010
Bing Hou, MD; Yuanchao Zhang, PhD
JAMA. 2010;304(20):2242-2243. doi:10.1001/jama.2010.1701.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

1 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.